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Abstract 
 
The structure-activity relationship of the complex between thrombin and 
thrombin binding aptamers (TBA) was evaluated by differential pulse voltammetry at a 
glassy carbon electrode and atomic force microscopy at a highly oriented pyrolytic 
graphite electrode. The effects on the interaction with thrombin of TBA primary and 
secondary structures as well as of its folding properties in the presence of alkaline 
metals were investigated. The complex between thrombin and single stranded aptamers 
involved the coiling of the single stranded molecules around thrombin structure leading 
to the formation of a robust TBA-thrombin complex that maintains the symmetry and 
conformation of the thrombin molecule. Monitoring both thrombin and TBA oxidation 
peaks, showed that the thrombin oxidation peaks occur at more positive potentials after 
TBA-thrombin complex formation. In the presence of K+ ions, the aptamers fold into 
quadruplex structures that facilitate the interaction with thrombin molecules. The TBA-
thrombin complex adsorbs at the surface with the aptamer quadruplex always in 
preferential contact with the surface, and the thrombin molecules on top of the aptamer 
quadruplex structure, thus being less accessible to the electrode surface leading to the 
occurrence of thrombin oxidation peaks at less positive potentials. 
 
Keyword: thrombin, aptamer, quadruplex, guanine, AFM, electrochemistry, oxidation. 
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1 Introduction 
 
Thrombin is a serine protease and a coagulation protein in the blood stream that 
has many effects on the coagulation mechanism [1-3]. The activation of thrombin is a 
crucial process in physiological and pathological coagulation and various rare diseases 
involving thrombin have been described. For example, blood from a ruptured cerebral 
aneurysm clots around a cerebral artery and releases thrombin, which can induce an 
acute and prolonged narrowing of the blood vessel, potentially resulting in cerebral 
ischemia and infarction (stroke). In order to treat these diseases, potent and specific 
antithrombotic agents are required and their development continues to be an area of 
intensive research. These inhibitors must show the adaptation of natural inhibitors to the 
unique molecular architecture of thrombin [1].  
Aptamers are DNA or RNA molecules that can be selected from random pools 
based on their ability to bind other molecules [4-7]. Aptamers have been selected to 
bind other nucleic acids, proteins, small organic compounds, and even entire organisms. 
They offer several advantages over antibodies, owing to their relative ease of isolation 
and modification, tailored binding affinity, and resistance to denaturizing [6]. Research 
focused on aptamers has exhibited promising potential in various fields such as 
pharmaceutics and diagnostics [8].  
Aptamers with strong affinity for a wide range of protein targets have been 
identified [4-10]. One of the most intensely studied aptamers is the thrombin binding 
aptamer (TBA), the DNA 15-mer 5’-GGTTGGTGTGGTTGG-3’ oligonucleotide that 
specifically binds to thrombin, inhibiting its activity [5, 11, 12]. It has been shown that 
TBA forms a unimolecular quadruplex in K+ ion containing solution, arranged in a 
chair-like structure, consisting of two G-quartets connected by two TT loops and a 
  
4 
single TGT loop. It is this structure that has a great influence in the inhibition process of 
thrombin by TBA. However, the knowledge of the thrombin 3-dimensional structure 
also has a crucial importance in understanding this binding process.  
A particularly striking feature of the thrombin molecule [13], Scheme 1, is its 
pronounced uneven charge distribution resulting in high positive and negative 
electrostatic field strengths outside the thrombin surface [2, 14]. In addition to the active 
site and the adjacent hydrophobic pocket (the apolar binding site), there are two 
electropositive exosites, the fibrinogen-recognition exosite at the base of the active-site 
cleft, and a more strongly electropositive heparin-binding exosite. It has been 
demonstrated that TBA does not interact with the active site of thrombin but with both 
exosites I and II [14, 15].  
The detection and quantification of proteins play an essential role in 
fundamental research and clinical applications [16-19]. Different strategies for thrombin 
detection have been used and the combination of the perfect sensitivity and specificity 
of biologically active molecules with suitable transducers allowed the development of 
several types of biosensors [20-26]. Most of these biosensors involve complicated 
architectures and the detection of the binding processes is done through different 
mediators by optical and electrochemical transduction. Therefore, the characterization 
of the binding process between thrombin and TBA without any labelling emerges as a 
necessary step for the development and characterization of more sensitive detection 
devices. Moreover, the characterization of the thrombin-TBA complex is essential for 
the understanding of the factors involved in the binding process between thrombin and 
TBA. 
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The present paper is the first report of a systematic study to elucidate the 
mechanism of interaction of two different sequences, Scheme 2, thrombin binding 
aptamer (TBA, 5'-GGTTGGTGTGGTTGG-3') and extended thrombin binding aptamer  
(eTBA, 5'-GGGTTGGGTGTGGGTTGGG-3') [27, 28] with thrombin. The study was 
carried out on two different types of carbon electrode, glassy carbon using differential 
pulse voltammetry and highly oriented pyrolytic graphite using magnetic AC mode 
atomic force microscopy.  
 
2 Experimental 
 
2.1 Materials and reagents 
Thrombin from Human Plasma obtained from Sigma-Aldrich was used without 
further purification. The ODN sequences TBA and eTBA, were synthesized on an ABI 
3400 DNA Synthesizer (Applied Biosystems, Foster City, CA, USA) using the 200-
nmol scale synthesis cycle [27]. All solutions were prepared using analytical grade 
reagents and purified water from a Millipore Milli-Q system (conductivity ≤ 0.1 µS cm-
1). Stock thrombin, TBA and eTBA solutions were prepared in Milli Q water and kept at 
4 ºC. Before each experiment, solutions of thrombin, TBA or eTBA were freshly 
prepared by dilution of the appropriate quantity in pH 7.0 0.1 M phosphate buffer (0.2 
M Na2HPO4 + 0.2 M NaH2PO4). The designation for the single stranded aptamers of ss-
TBA and ss-eTBA and for the quadruplex aptamers of qs-TBA and qs-eTBA will be 
used. 
Microvolumes were measured using EP-10 and EP-100 Plus Motorized 
Microliter Pippettes (Rainin Instrument Co. Inc., Woburn, USA). The pH measurements 
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were carried out with a Crison micropH 2001 pH-meter with an Ingold combined glass 
electrode. All experiments were done at room temperature (25 ± 1 ºC). 
 
2.2 Atomic force microscopy 
The substrate used in magnetic AC mode atomic force microscopy (MAC mode 
AFM) study was highly oriented pyrolytic graphite (HOPG), grade ZYB of dimensions 
15 x 15 x 2 mm3, from Advanced Ceramics Co., USA. The HOPG was freshly cleaved 
with adhesive tape prior to each experiment and imaged by AFM in order to establish its 
cleanliness.  
AFM was performed in the AAC mode AFM, with a PicoScan controller from 
Agilent Technologies, Tempe, AZ, USA. All the AFM experiments were performed 
with a CS AFM S scanner with a scan range of 6 m in x-y and 2 m in z, from Agilent 
Technologies. AppNano type FORT of 225 m length, 3.0 N m-1 spring constants and 
47 – 76 kHz resonant frequencies in air (Applied NanoStructures, Inc., USA) were used. 
All AFM images were topographical and were taken with 256 samples/line x 256 lines 
and scan rates of 0.8 – 2.0 lines s-1. When necessary, the AFM images were processed 
by flattening in order to remove the background slope and the contrast and brightness 
were adjusted.  
 
2.3 Sample preparation for AFM 
TBA–thrombin and eTBA–thrombin solutions were prepared by incubation at 
room temperature of 1 µg mL-1 TBA or eTBA with 0.25 µg mL-1 or 10 µg mL-1 of 
thrombin in pH 7.0 0.1 M phosphate buffer. To study the influence of the K+ ions, the 
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incubation of the TBA-thrombin and eTBA-thrombin solutions was performed in the 
presence of 100 mM KCl. 
The thrombin, TBA, eTBA, TBA–thrombin and eTBA–thrombin modified 
HOPG surfaces were obtained by depositing 200 L samples of the appropriate solution 
of thrombin, TBA, eTBA, TBA–thrombin or eTBA–thrombin solutions onto the freshly 
cleaved HOPG surface, during 5 min. The excess of solution was gently removed by 
cleaning with a jet of Millipore Milli-Q water, and the HOPG with adsorbed molecules 
was then dried in a sterile atmosphere and imaged by AAC Mode AFM in air.  
 
2.4 Voltammetric parameters and electrochemical cells 
Voltammetric experiments were carried out using a µAutolab running with 
GPES 4.9 software, Metrohm/Autolab, Utrecht, The Netherlands. Measurements were 
carried out using a glassy carbon (GCE, d = 1.5 mm) working electrode, a Pt wire 
counter electrode, and a Ag/AgCl as reference, in a 0.25 mL electrochemical cell. The 
experimental conditions for differential (DP) voltammetry were pulse amplitude 50 mV, 
pulse width 70 ms, and scan rate 5 mV s-1. 
The GC electrode was polished using diamond spray (particle size 1 µm) before 
each experiment. After polishing, the electrode was rinsed thoroughly with Milli-Q 
water and placed in supporting electrolyte and various DP voltammograms were 
recorded until a steady state baseline voltammogram was obtained. This procedure 
ensured very reproducible experimental results. 
All results have been repeated several times with good reproducibility. It must 
be mentioned that each measurement was always done using a freshly polished GCE, a 
process that give rise to small modifications of the electrode surface area which can in 
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turn cause variations in the current, however lower than 5 % and this is the main source 
of differences in the currents in the procedures described.  
 
2.6 Sample preparation for voltammetry 
TBA-thrombin and eTBA-thrombin solutions were prepared by incubation at 
room temperature of 1 µg mL-1 TBA/eTBA with 1 µg mL-1 of thrombin in pH 7.0 0.1 M 
phosphate buffer. 
To study the influence of the K+ ion concentration, two different experiments 
were carried out. In the first, the incubation of the TBA-thrombin and eTBA-thrombin 
solutions was performed in the presence of 100 mM KCl. In the second, TBA or eTBA 
were incubated during 24 h with 100 mM KCl in order to obtain the formation of the 
quadruplexes and than incubated with thrombin.  
 
2.5 Acquisition and presentation of voltammetric data 
The DP voltammograms were baseline-corrected using the moving average with 
a step window of 2 mV included in GPES version 4.9 software. This mathematical 
treatment improves the visualization and identification of peaks over the baseline 
without introducing any artefact, although the peak height is in some cases reduced 
(<10%) relative to that of the untreated curve. Nevertheless, this mathematical treatment 
of the original voltammograms was used in the presentation of all experimental 
voltammograms for a better and clearer identification of the peaks. The values for peak 
current presented in all plots were determined from the original untreated 
voltammograms after subtraction of the baseline. 
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3 Results  
 
3.1 Adsorption process and redox behaviour of thrombin 
3.1.1 AFM characterization of adsorbed thrombin 
The capacity of thrombin to interact and adsorb on carbon electrode surfaces 
was investigated using AFM in air. The thrombin modified HOPG was obtained by 
spontaneous adsorption during 5 min, from solutions of either 0.25 or 10 µg mL–1 
thrombin, using the method described in Section 2.3. 
AFM images of the thrombin modified HOPG obtained from a solution of  
0.25 µg mL–1 thrombin in pH 7.0 0.1 M phosphate buffer, showed the formation of 
aggregates of 2.0 – 4.0 of height, presenting the tendency to attach near the defects on 
the HOPG step edges, Fig. 1A. Increasing the concentration of thrombin to 10 µg mL–1, 
a large number of aggregates clusters could be observed in the images, Fig. 1B and C, 
presenting heights of 3.9 ± 0.6 nm.  
Since a greater adsorption of thrombin was observed for 10 µg mL–1 
concentrated solutions allowing a better visualization on the AFM images, all 
experiments were carried out in these conditions. 
 
3.1.2 Voltammetric characterization of thrombin, TBA and eTBA 
DP voltammograms were recorded with the clean GCE in solutions of thrombin 
of different concentrations in pH 7.0 0.1 M phosphate buffer. Two consecutive peaks, 
T1 at Epa1 = + 0.76 V, and T2 at Epa2 = + 0.90 V, Fig. 1D, were always observed at the 
same potentials with currents varying proportionally to the concentration.  
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DP voltammograms in pH 7.0 0.1 M phosphate buffer in solutions of 1 µg mL-1 
ss-TBA and ss-eTBA showed a main oxidation peak G at EpaG = + 0.88 mV, due to the 
oxidation of guanine residues [28]. This peak presented higher currents in the case of 
eTBA, in agreement with a greater number of guanine residues when compared with 
TBA. Upon formation of the quadruplexes (qs), the DP voltammograms showed a 
smaller peak G for both aptamers. Nevertheless, in the case of qs-eTBA a new peak Gq 
occurred at more positive potentials and this peak, previously characterized, is specific 
to the G-quadruplex oxidation [28].  
 DP voltammograms were also obtained with different concentrations of 
thrombin incubated with solutions of 1 µg mL–1 TBA or eTBA. Higher peaks and a 
better separation of the electrochemical signals of thrombin, TBA or eTBA, were 
observed for concentrations of 1 µg mL–1 thrombin and so all further experiments were 
carried out in these conditions. 
 
3.2 Interaction of thrombin binding aptamers with the thrombin 
3.2.1 AFM evaluation of TBA–thrombin and eTBA–thrombin interaction 
The mechanism of interaction with thrombin of both thrombin binding aptamers, 
TBA and eTBA, was investigated and characterized by AFM. The TBA–thrombin or 
eTBA–thrombin modified HOPG surfaces were obtained as described in Section 2.3, by 
spontaneous adsorption from incubated solutions of 1 µg mL-1 TBA or eTBA with  
10 µg mL-1 thrombin in pH 7.0 0.1 M phosphate buffer, during several periods of time. 
This procedure led to co-adsorption of TBA or eTBA–thrombin, free TBA or eTBA and 
free thrombin molecules.  
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The stabilisation of the quadruplex structures requires the presence of metal 
ions, in particular alkali metals, and the order of preference is K+ > Na+. Both buffer 
solutions used in this study contain only Na+, although acetate buffer contains a lower 
Na+ concentration than the phosphate buffer solution. In order to establish the influence 
of the presence of K+ in the formation and stabilisation of TBA and eTBA 
quadruplexes, modifying their interaction with thrombin, the morphological 
characteristics of TBA–thrombin or eTBA–thrombin modified HOPG surfaces obtained 
from solutions of TBA–thrombin and eTBA–thrombin incubated in the presence of 100 
mM KCl during different periods of time, were also analysed. 
AFM images of the ss-TBA-thrombin modified HOPG, obtained after 
adsorption from pH 7.0 0.1 M phosphate buffer, 1 µg mL–1 TBA and 10 µg mL–1 
thrombin solutions without incubation, showed almost complete HOPG surface 
coverage by a network film of 0.9 ± 0.1 nm height, with embedded 2.3 ± 0.4 nm height 
spherical aggregates. After 24 h of incubation, Fig. 2A, the height of the network was 
1.0 ± 0.3 nm and of the aggregates 2.5 ± 0.1 nm.  
A more complicated situation was observed for qs-TBA-thrombin formed after 
the addition of K+ ions and incubation during 24 h, Fig. 2B. The HOPG surface 
coverage decreased drastically and patches of a thick layer with bulky, knotty 
appearance were observed  due to the existence of a large number of aggregates 
embedded into its structure. The heights of the layer were very heterogeneous, between 
1.0 and 3.6 nm.  
The interaction between thrombin and eTBA was also evaluated by AFM.  
The AFM images of the ss-eTBA-thrombin modified HOPG obtained after adsorption 
from pH 7.0 0.1 M phosphate buffer, 1 µg mL–1 eTBA and 10 µg mL–1 thrombin 
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solutions incubated during 1 h, Fig. 3A, showed the HOPG surface covered by an  
incomplete ss-eTBA–thrombin but thick network, with knotty appearance and  
2.3 ± 0.5 nm height. After 24 h of incubation in the presence of only Na+ cations,  
Fig. 3B, the AFM images showed the formation of the thick, 2.9 ± 0.7 nm height areas 
that were previously observed after short incubation times.  
AFM images of the qs-eTBA–thrombin modified HOPG, obtained after 
adsorption from pH 7.0 0.1 M phosphate buffer, 1 µg mL–1 qs-eTBA and 10 µg mL–1 
thrombin solutions in the presence of 100 mM K+, showed a mixed pattern of 
adsorption after both 1 h, Fig. 3C, and 24 h, Fig. 3D, of incubation with 2.9 ± 0.3 nm 
thickness and 3.4 ± 0.4 nm height. 
 
3.2.2 Voltammetric evaluation of TBA–thrombin and eTBA–thrombin interaction 
The interaction of thrombin and TBA was investigated after incubation of 
 1 µg mL-1 thrombin with 1 µg mL-1 TBA in pH 7.0 0.1 M phosphate buffer.  
The DP voltammograms were recorded after different incubation periods and between 
experiments the GCE surface was always cleaned in order to avoid poisoning of the 
electrode surface with TBA and/or thrombin oxidation products formed after successive 
voltammograms in solution.  
The DP voltammograms recorded immediately after the addition of 1 µg mL-1 
ss-TBA to the solution of 1 µg mL-1 thrombin in pH 7.0, Fig. 2C, showed the two peaks 
of thrombin, T1 and T2, and the oxidation peak G of ss-TBA. No differences in the 
potential and current when compared with the voltammograms in the solution 
containing only thrombin or TBA were observed. Increasing the incubation times, both 
thrombin oxidation peaks, T1 and T2, occurred with the same current but at a higher 
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potential, ∆Ep ~ 20 mV. Additionally, peak G was not observed. An increase of the peak 
at Ep ~ + 0.90 V was observed in the DP voltammograms after different incubation 
times due to the overlapping of ss-TBA oxidation peak G and of thrombin oxidation 
peak T2. Nevertheless, thrombin peak T1 occurred always with the same current.  
The same experiments were carried out in a mixed solution of 1 µg mL-1 
thrombin and 1 µg mL-1 qs-TBA in pH 7.0. The DP voltammograms obtained without 
incubation, Fig. 2D, showed the occurrence of the thrombin oxidation peak T1 at the 
same potential and with the same current as the voltammograms recorded in the solution 
containing only thrombin. The increase in the current at Ep ~ +0.90 V, due to the 
overlapping of qs-TBA oxidation peak G and of thrombin oxidation peak T2 was 
observed. It is important to mention that upon formation of qs-TBA, peak G decreased 
drastically; hence it cannot be observed on this voltammograms. Increasing the 
incubation time, both peaks decreased in a time-dependent manner during 48 h of 
incubation after which constant currents were reached, Fig. 5.  
The interaction of thrombin with ss-eTBA was studied after incubation of  
1 µg mL-1 thrombin with 1 µg mL-1 eTBA in pH 7.0 0.1 M phosphate buffer. The DP 
voltammograms were recorded after different incubation periods and between 
experiments the GCE surface was always cleaned. The DP voltammograms recorded 
immediately after addition of 1 µg mL-1 eTBA to the solution of 1 µg mL-1 thrombin in 
pH 7.0, Fig. 4A, showed thrombin and eTBA oxidation peaks at the same potential and 
with the same current as in the voltammograms in the solution containing only thrombin 
or eTBA. A small increase of the thrombin oxidation potential of peaks, T1 and T2,  
∆Ep ~ 20 mV, was observed in the voltammograms recorded after different incubation 
periods. The peak at Ep ~ + 0.90 V showed an increase in current since it was due to 
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both thrombin peak T2 and peak G of eTBA. Nevertheless, thrombin peak T1 occurred 
always with the same current and potential.  
A different situation was observed when the experiments were carried out in a 
mixed solution of 1 µg mL-1 thrombin and 1 µg mL-1 qs-eTBA in pH 7.0. On the DP 
voltammograms recorded immediately after addition of qs-eTBA to the solution of 
thrombin, Fig. 4B, a new peak Gq due to the oxidation of eTBA quadruplexes was 
observed. On the other hand, thrombin peak T1 occurred with the same current as the 
voltammograms recorded in the solution containing only thrombin, while the peak at  
Ep ~ + 0.90 V was due to the overlapping of peaks T2 and G. The voltammograms 
obtained after different incubation times showed a gradual decrease of thrombin 
oxidation peak T1and of the peak at Ep ~ + 0.90 V. Nevertheless, peak Gq occurred 
always with the same current. The changes that occurred for both thrombin oxidation 
peaks were followed during 168 h incubation, Fig. 5. A faster decrease of thrombin 
oxidation currents was observed in the first 48 h of incubation, Fig. 5, but for longer 
times constant currents were reached. 
 
4 Discussion 
 
Protein adsorption is a complex phenomenon and both the biological activity and 
amount of adsorbed proteins depend on the properties of the substrate. Although the 
complex interactions between solid surfaces and proteins are not completely 
understood, it is believed that both short and long range forces including van der Waals 
interactions, electrostatic interactions, hydrogen bonding and particularly hydrophobic 
interactions are all very important in protein adsorption [21]. The thrombin molecule 
has only small hydrophobic moieties which are the active-site and the apolar binding 
  
15 
site (the adjacent hydrophobic pocket). For this reason, a small adsorption of thrombin 
at the HOPG surface was observed, Fig. 1 A-C. However, the voltammetric results 
showed that the thrombin molecule is oxidised presenting two peaks corresponding to 
its electroactive centres, Fig. 1D. 
In a previous report [28] it has been shown that, in the presence of K+ cations, 
due to the formation of very stable and rigid intramolecular quadruplex configurations, 
both TBA and eTBA adsorb less onto HOPG, compared to their adsorption in the 
presence of only Na+ cations, as in the pH 7.0 0.1M phosphate buffer. This is due to the 
fact that a larger number of intramolecular quadruplexes is formed, which are more 
stable due to the incorporation of K+, which prevents the aptamers hydrophobic 
interaction with HOPG. The presence of only Na+ cations led to the formation of less 
stable quadruplexes [29] that are locally destabilised by the HOPG hydrophobic surface, 
inducing the aptamers' greater adsorption together with the single-stranded sequences 
[28]. The voltammetric studies showed that both TBA and eTBA are oxidized at GCE 
and the only electrochemical signal is due to the oxidation of guanine residues, peak G. 
Upon addition of K+ ions, both TBA and eTBA fold into G-quadruplex structures, 
Scheme 2, and this process was observed by the decrease of the peak G and the 
occurrence of a new peak Gq at higher potential values due to the oxidation of guanine 
residues in the G-quartets [28].  
In the present study, the AFM and the voltammetric results for the interaction of 
thrombin with different structures of TBA and eTBA were evaluated.  
The AFM images obtained after the incubation of thrombin with ss-TBA or ss-
eTBA showed the formation of a network film with embedded aggregates that almost 
completely covered the HOPG surface, Table 1 and Figs. 2A, 3A and 3B. This film 
  
16 
involves the co-adsorption of ssTBA–thrombin or ss-eTBA–thrombin, free ss-TBA or 
ss-eTBA and free thrombin molecules. Increasing the incubation time, the height of 
both network and aggregates increased and this process is specific to the formation of 
the ssTBA-thrombin complex.  
The voltammetric results showed that, by increasing the incubation time, the 
peak currents of both thrombin oxidation peaks, T1 and T2, remain constant, but their 
potentials become more positive Figs. 2C and 4A, while peak G occurs at the same 
potential. This causes overlapping of the peaks T2 and G which explains the increase of 
the current observed at + 0.90 V on the DP voltammograms for longer incubation times. 
The increase in potential of peaks T1 and T2 may be explained considering the formation 
of ss-TBA-thrombin or ss-eTBA-thrombin complexes that do not involve either of 
thrombin exocites but the coiling of the single stranded molecules around parts of the 
thrombin structure. This interaction is most probably electrostatic and occurs between 
the negatively charged phosphate backbone of the aptamers and positive electrostatic 
field strength outside the thrombin surface leading to the formation of a robust complex 
as was also shown by the AFM images. Therefore, the transition of electrons from the 
inside of the rigid aptamer-thrombin complex to the GCE surface is more difficult than 
from the more flexible thrombin molecule that can reach the surface more easily leading 
to higher peak currents. 
A complicated situation was observed after the incubation of thrombin with  
qs-TBA or qs-eTBA. The AFM images showed patches of a thick layer with a bulky, 
knotty appearance due to the existence of a large number of embedded aggregates into 
its structure, Figs. 2B, 3C and 3D. The heights of the layer were very heterogeneous, 
varying between 1.0 and 3.6 nm, Table 1. The decrease of adsorption when compared 
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with the interaction between ss-TBA or ss-eTBA and thrombin is explained by a 
reduced number of single stranded oligonucleotides that may adsorb at the HOPG 
surface. On the other hand, considering that qs-TBA or qs-eTBA can interact with either 
both or any of the thrombin exocites, this layer may be due to the adsorption of at least 
three types of aggregates dictated by the interaction with either one or both thrombin 
exocites.  
In agreement with the AFM results, the voltammetric studies have shown that, 
increasing the incubation time, the decrease of both thrombin oxidation peaks T1 and T2 
occurs, Figs. 2D and 4B. This effect is specific to conformational changes in biological 
molecules, but the occurrence of structural modification of thrombin upon binding of  
qs-TBA or qs-eTBA is improbable considering previous studies [30]. On the other 
hand, it has been shown that the Gq peak remains constant, maintaining the same current 
even for long incubation times, suggesting that upon incubation the qs-TBA or qs-eTBA 
are always in contact with the electrode surface. The thrombin molecules lie on top of 
the aptamer quadruplex structure: the reduced contact between thrombin molecules and 
the GCE surface leads to the occurrence of lower oxidation peak, T1 and T2, currents.  
In order to study the influence of the K+ ions on the TBA or eTBA interaction 
with thrombin, two different voltammetric experiments were carried out. In one 
experiment TBA or eTBA were incubated during 24 h with 100 mM KCl, in order to 
form the quadruplexes, and afterwards incubated with thrombin, as described above. In 
the other experiment the incubation of the TBA-thrombin and eTBA-thrombin solutions 
was performed in the presence of 100 mM KCl in order that the formation of the 
aptamer quadruplex occurred in the presence of thrombin. Nevertheless, similar results 
were obtained in both cases.  
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4 Conclusion 
 
A systematic study of the interaction between thrombin and two different 
thrombin binding aptamer sequences was carried out on two different types of carbon 
electrode, GCE using DP voltammetry and HOPG using MAC mode AFM.  
The AFM results obtained after the incubation of thrombin with single stranded 
aptamers showed for low incubation times the co-adsorption of aptamer–thrombin, free 
aptamer and free thrombin molecules. Increasing the incubation time, the height of the 
aggregates increased in agreement with the formation of the aptamer-thrombin complex. 
The voltammetric results confirm these data and show that thrombin oxidation peaks 
occur at more positive potentials upon complex formation. This behaviour is explained 
considering coiling of the single stranded aptamer molecules around the thrombin 
structure leading to the formation of a more robust complex that maintains the 
conformation of the thrombin molecules. 
After incubation of thrombin with quadruplex aptamers a complicated situation 
was observed. The AFM images showed patches of a thick layer with a bulky, knotty 
appearance due to the existence of a large number of embedded aggregates into its 
structure corresponding to the adsorption of different types of aggregates dictated by the 
interaction with either one or both thrombin exocites. The voltammetric data suggested 
that upon interaction with thrombin, the quadruplexes are always in contact with the 
electrode surface whereas the thrombin molecules lie above the quadruplex structure 
which reduces their contact with the electrode surface leading to the occurrence of 
lower thrombin oxidation peaks.  
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Table 1 – Thrombine, TBA, eTBA, TBA–thrombine and eTBA–thrombine modified 
HOPG morphological characteristics by AFM. 
 
Solution in pH 7.0 0.1 M phosphate buffer Adsorption pattern and heights Time Figure 
10 µg mL–1 thrombin - 3.9 ± 0.6 nm aggregates clusters  1C 
- 
0.8 ± 0.1 nm network/fragments (ss-TBA) 
1.9 ± 0.5 nm aggregates (qs-TBA) 
 [27] 
1 µg mL-1 TBA 
+ 100 mM K+ 0.8 ± 0.1 nm network/fragments (ss-TBA)  [27] 
0.9 ± 0.1 nm network  
2.3 ± 0.4 nm aggregates 
1 h 
not 
shown 
- 
1.0 ± 0.3 nm network  
2.5 ± 0.1 nm aggregates 
24 h 2A 
1 µg mL–1 TBA  
+ 10 µg mL–1 thrombin 
+ 100 mM K+ 1.0–3.6 nm thick, bulky, knotty film 24 h 2B 
- 
0.8 ± 0.1 nm network/fragments (ss-eTBA) 
1.5 ± 0.5 nm aggregates (qs-eTBAs) 
1 h [27] 
1 µg mL-1 eTBA 
+ 100 mM K+ 0.8 ± 0.1 nm network/fragments (ss-eTBA) 
few 1.5 ± 0.5 nm aggregates (qs-TBAs) 
24 [27] 
2.3 ± 0.5 nm thick film  1 h 4A 
- 
2.9 ± 0.7 nm thick, bulky, knotty film 24 h 4B 
2.9 ± 0.7 nm thick, bulky, knotty film 1 h 4C 
1 µg mL–1 eTBA  
+ 10 µg mL–1 thrombin 
 + 100 mM K+  
3.4 ± 0.4 nm thick, bulky, knotty film 24 h 4D 
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Figures 
 
Scheme 1 - Representations of the tertiary structure of thrombin generated by  
PDB Protein Workshop 3.8 (Powered by MBT) [13]. (A) Two main peptide 
chains are observed. Chain A at the top of the molecule and the heavier chain B 
below. (B) Representation of thrombin exocites I and II [2].  
 
Scheme 2 - Schematic representation of anti-parallel quadruplex structures of (A) TBA 
and (B) eTBA. 
 
Figure 1 - AFM topographical images in air of a thrombin modified HOPG surface, 
obtained by spontaneous adsorption during 5 min, from solutions of  
(A) 0.25 and (B, C) 10 µg mL-1 thrombin in pH 7.0 0.1 M phosphate buffer. 
(D) DP voltammograms base line corrected obtained with the GCE in solution 
of () 0.25, () 0.50 and (•••) 1.00 µg mL-1 thrombin in pH 7.0 0.1 M 
phosphate.  
 
Figure 2 - AFM topographical images in air of a TBA–thrombin modified HOPG, 
obtained by spontaneous adsorption during 5 min from incubated solutions in 
pH 7.0 0.1 M phosphate buffer of 1 µg mL-1 TBA with 10 µg mL-1 thrombin, 
(A) in the absence and (B) in the presence of 100 mM K+, after 24 h of 
incubation. (C, D) DP voltammograms base line corrected obtained with the 
GCE in incubated solutions of 1 µg mL-1 thrombin incubated with 1 µg mL-1 
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(C) ss-TBA and (D) qs-TBA in pH 7.0 0.1 M phosphate buffer during  
(•••) 0, () 1 and () 48 h.  
 
Figure 3 - AFM topographical images in air of eTBA–thrombin, immobilised on the 
HOPG surface by spontaneous adsorption during 5 min, from an incubated 
solution of 10 µg mL-1 thrombine with 1 µg mL-1 eTBA in pH 7.0 0.1 M 
phosphate buffer, (A, B) in the absence and (C, D) in the presence of  
100 mM K+, after (A, C) 1 h and (B, D) 24 h of incubation. 
 
Figure 4 - DP voltammograms base line corrected obtained with the GCE in incubated 
solutions of 1 µg mL-1 thrombin with 1 µg mL-1 (A) ss-eTBA and (B) qs-eTBA 
in pH 7.0 0.1 M phosphate buffer during (•••) 0, () 1 and () 48 h.  
 
Figure 5 - Plot of the variation with incubation time of thrombin oxidation peaks  
(, ) T1 and (, ) T2 after incubation with 1 µg mL-1 (,) qs-TBA and 
(,) qs-eTBA. 
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Scheme 1 - Representations of the tertiary structure of thrombin generated by PDB 
Protein Workshop 3.8 (Powered by MBT) [13]. (A) Two main peptide chains are 
observed. Chain A at the top of the molecule and the heavier chain B below. (B) 
Representation of thrombin exocites I and II [2].  
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Scheme 2 - Schematic representation of anti-parallel quadruplex structures of (A) TBA 
and (B) eTBA. 
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Figure 1 - AFM topographical images in air of a thrombin modified HOPG surface, 
obtained by spontaneous adsorption during 5 min, from solutions of (A) 0.25 and  
(B, C) 10 µg mL-1 thrombin in pH 7.0 0.1 M phosphate buffer. (D) DP voltammograms 
base line corrected obtained with the GCE in solution of () 0.25, () 0.50 and  
(•••) 1.00 µg mL-1 thrombin in pH 7.0 0.1 M phosphate.  
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Figure 2 - AFM topographical images in air of a TBA–thrombin modified HOPG, 
obtained by spontaneous adsorption during 5 min from incubated solutions in pH 7.0 
0.1 M phosphate buffer of 1 µg mL-1 TBA with 10 µg mL-1 thrombin,  
(A) in the absence and (B) in the presence of 100 mM K+, after 24 h of incubation.  
(C, D) DP voltammograms base line corrected obtained with the GCE in incubated 
solutions of 1 µg mL-1 thrombin incubated with 1 µg mL-1 (C) ss-TBA and (D) qs-TBA 
in pH 7.0 0.1 M phosphate buffer during (•••) 0, () 1 and () 48 h.  
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Figure 3 - AFM topographical images in air of eTBA–thrombin, immobilised on the 
HOPG surface by spontaneous adsorption during 5 min, from an incubated solution of 
10 µg mL-1 thrombine with 1 µg mL-1 eTBA in pH 7.0 0.1 M phosphate buffer,  
(A, B) in the absence and (C, D) in the presence of 100 mM K+, after (A, C) 1 h and  
(B, D) 24 h of incubation. 
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Figure 4 - DP voltammograms base line corrected obtained with the GCE in incubated 
solutions of 1 µg mL-1 thrombin with 1 µg mL-1 (A) ss-eTBA and (B) qs-eTBA in  
pH 7.0 0.1 M phosphate buffer during (•••) 0, () 1 and () 48 h.  
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Figure 5 -Plot of the variation with incubation time of thrombin oxidation peaks  
(, ) T1 and (, ) T2 after incubation with 1 µg mL-1  
(,) qs-TBA and (,) qs-eTBA. 
 
